newsfilter
← Earnings
Earnings Releases·

AVITA Medical — Third Quarter 2026 Earnings Summary

AVITA Medical reported third-quarter 2026 total revenue of $26.1 million, representing a 53% year-over-year increase driven by growth in RECELL and Cohealyx products. The company raised its full-year 2026 revenue guidance to a range of $92 million to $94 million and reaffirmed its expectation of achieving cash flow breakeven in the fourth quarter. Gross margin improved to 84.0% year-over-year, while the company drew an additional $10 million tranche from its credit facility after reaching an $85 million trailing twelve-month revenue milestone. Additionally, the company removed the going concern qualification from its financial reports due to improved operating performance and liquidity.

Company
AVITA MEDICAL INC
Sector
Healthcare
Industry
Medical Devices